Estrogen-related Receptor Alpha (ERRα; NR3B1)
|Product Family||Product Number||Product Description||Technical Manual|
|IB08001-32||Human ERRα Reporter Assay System, 3 x 32 assays in 96-well format||Technical Manual|
|IB08001||Human ERRα Reporter Assay System, 1 x 96-well format assays||Technical Manual|
|IB08002||Human ERRα Reporter Assay System, 1 x 384-well format assays|
Kits are offered in different assay formats to accommodate researchers’ needs: 3 x 32, 1 x 96, and 1 x 384 assay formats for screening small numbers of test compounds, as well as custom bulk reagents for HTS applications. Assay systems are all inclusive, providing reporter cells, optimized growth media, media for diluting test compounds, an inverse-agonist, luciferase detection reagent, a white assay plate, a detailed protocol, and a protocol quick guide. All kits are shipped on dry ice.
ERRα Reporter Cells are prepared using INDIGO’s proprietary CryoMite™ process. This cryo-preservation method yields high cell viability post-thaw, and provides the convenience of immediately dispensing healthy, division-competent reporter cells into assay plates. There is no need for intermediate spin-and-wash steps, viability determinations, or cell titer adjustments.
The principle application of this assay product is in the screening of test samples to quantify inverse-agonist activities that they may exert against human ERRα. This kit product is an all-inclusive assay system that includes, in addition to ERRα Reporter Cells, two optimized media for use during cell culture and (optionally) in diluting the test samples, a reference inverse-agonist, Luciferase Detection Reagent, a cell culture-ready assay plate, and a detailed protocol.
Bulk assay reagents can be custom manufactured to accommodate any scale of HTS. Please inquire.
These nuclear receptor assay systems utilize proprietary human mammalian cells engineered to provide high-level expression of a hybrid form of Human ERRα (also known as NR3B1).
Reporter Cells also incorporate a responsive luciferase reporter gene. Quantifying expressed luciferase activity at the assay endpoint provides a sensitive surrogate measure of changes in ERRα activity in treated cells. As is true in vivo, these reporter cells express ERRα in a constitutive state of high-level activity. Therefore, the principle application of this assay system is in the screening of test samples to quantify inverse-agonist activities that they may exert against human ERRα.
For more information on ERRα, visit the Nuclear Receptor Resource.
Service Assays: Human
The primary application of INDIGO’s cell-based nuclear receptor assays are to quantitatively assess the bioactivity of a test compound as an agonist (activator) or antagonist (inhibition of an agonist response) of a given receptor. Service assays include a positive control reference compound and ‘vehicle’ control for every experiment. A formal study report and all data files are provided to the client upon completion of the study. To receive a quote for your proposed study, complete & submit the online “Request a Quote” form or contact an INDIGO Customer Service Representative to discuss your desired study parameters.
November 7, 2013 – The Nuclear Receptor Experts™ are expanding the line of INDIGO Nuclear Receptor Reporter Assays. Human Estrogen-Related Receptor Alpha (ERRa) is available in INDIGO’s Contract Screening Lab or can be purchased as INDIGO Nuclear Receptor Reporter Assay Kits. The principle application of this assay system is in the screening of test samples